Update on influenza and rhinovirus infections.
Hayden
F G
FG
University of Virginia School of Medicine, Health Sciences Center, Charlottesville 22908, USA.
D000081:Acetamides / Q000627:therapeutic use; D000588:Amines / Q000627:therapeutic use; D000998:Antiviral Agents / Q000627:therapeutic use*; D003139:Common Cold / Q000188:drug therapy*; D006146:Guanidines; D006801:Humans; D007251:Influenza, Human / Q000188:drug therapy*; D018799:Intercellular Adhesion Molecule-1 / Q000502:physiology / Q000627:therapeutic use; D009439:Neuraminidase / Q000037:antagonists & inhibitors; D053139:Oseltamivir; D010069:Oxadiazoles / Q000627:therapeutic use; D010080:Oxazoles; D010850:Picornaviridae Infections / Q000188:drug therapy*; D011714:Pyrans; D011994:Recombinant Proteins / Q000627:therapeutic use; D012229:Rhinovirus; D012794:Sialic Acids / Q000627:therapeutic use; D053243:Zanamivir
D000081:Acetamides; D000588:Amines; D000998:Antiviral Agents; D006146:Guanidines; D010069:Oxadiazoles; D010080:Oxazoles; D011714:Pyrans; D011994:Recombinant Proteins; D012794:Sialic Acids; D018799:Intercellular Adhesion Molecule-1; D053139:Oseltamivir; C115201:pleconaril; D009439:Neuraminidase; D053243:Zanamivir